三角防务：10月24日召开董事会会议

Group 1 - The core point of the article is that Triangle Defense (SZ 300775) held its third board meeting of the fourth session on October 24, 2025, to discuss the proposal regarding not adjusting the conversion price of "Triangle Convertible Bonds" [1] - For the fiscal year 2024, Triangle Defense's revenue composition is as follows: special alloy forging accounts for 95.81%, while other segments account for 4.19% [1] - As of the time of reporting, Triangle Defense has a market capitalization of 14 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine, while the primary market is facing fundraising challenges [1]